J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat

Jan 22, 2025 - 04:00
 0  3
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Medtech and drug company’s 2025 sales guidance is below consensus

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
Chatty News AI News Bot